Citation data

Scopus by Title (Ref)

Articles that cite the referenced work, matched by title from the Scopus database.

20 resultsUpdated October 18, 2026

← Back to article

1

Chitosan nanoparticles for mucosal and needle-free vaccination

Npj Vaccines

December 2026

Chen C.

Open Access

2

QUALITY CONTROL TESTING OF THE CLOSTRIDIAL VACCINE, ADVANTAGES AND CHALLENGES ‒ A COMPREHENSIVE REVIEW

Bulgarian Journal of Veterinary Medicine

2026

Abdolmohammadi Khiav L.

Open Access

3

A review on the utilization of insect chitosan in the food industry: Challenges and opportunities

International Journal of Biological Macromolecules

November 2025

Gul T.

4

Status and Challenges for Vaccination against Avian H9N2 Influenza Virus in China

Life

September 2022

Dong J.

Open Access

5

A Combination of Recombinant HA1-and Nucleoprotein-Based Chitosan Nanoparticles Induces Early and Potent Immune Responses Against the H9N2 Influenza Virus

Viral Immunology

1 June 2022

Shahsavandi S.

6

High resolution imaging of viruses: Scanning probe microscopy and related techniques

Methods

January 2022

Akhmetova A.I.

7

Comparative Study on the Efficacy of MF 59, ISA70 VG, and Nano-Aluminum Hydroxide Adjuvants, Alone and with Nano-Selenium on Humoral Immunity Induced by a Bivalent Newcastle+Avian Influenza Vaccine in Chickens

Archives of Razi Institute

November 2021

Radmehri M.

8

Self-Assembled Nanoparticles: Exciting Platforms for Vaccination

Biotechnology Journal

December 2020

Pan J.

Open Access

9

Intranasal vaccine using p10 peptide complexed within chitosan polymeric nanoparticles as experimental therapy for paracoccidioidomycosis in murine model

Journal of Fungi

September 2020

Santos Junior S.R.D.

Open Access

10

Effectiveness of chitosan nanoparticles in development of pentavalent clostridial toxoid vaccine in terms of clinical pathology elements and immunological responses

Archives of Razi Institute

1 June 2020

Fathi Najafi M.

11

Chitosan and chitosan nanoparticles as adjuvant in local Rift Valley Fever inactivated vaccine

3 Biotech

1 March 2020

El-Sissi A.F.

All Open Access, Green

12

Full-genome characterization and genetic analysis of a H9N2 virus in commercial broilers in Iran, 2017

Tropical Animal Health and Production

1 July 2019

Fallah Mehrabadi M.H.

13

Nutritional and immunological effects of nano-particles in commercial poultry birds

World S Poultry Science Journal

2019

Anwar M.I.

14

Adjuvants of influenza vaccines: New possibilities of using sulphated polysaccharides from marine brown algae

Voprosy Virusologii

2019

Kuznetsova T.A.

Open Access

15

Improvement efficacy of influenza nanovaccine in combination with Hemokinin-1 molecular adjuvant

Avicenna Journal of Medical Biotechnology

October-December 2018

Dehghan A.

16

Immunogenicity of concentrated and purified inactivated avian influenza vaccine formulation

Archives of Razi Institute

2018

Nazari A.

17

Evaluation of lipopeptide biosurfactants produced from native strains of Bacillus cereus as adjuvant in inactivated low pathogenicity avian influenza H9N2 vaccine

International Journal of Agriculture and Biology

2018

Basit M.

18

Geniposide demonstrates anti-inflammatory and antiviral activity against pandemic A/Jiangsu/1/2009 (H1N1) influenza virus infection in vitro and in vivo

Antiviral Therapy

2017

Zhang Y.

19

Evaluation of different chemical adjuvants on an avian influenza H6 DNA vaccine in chickens

Avian Pathology

1 November 2016

Shan S.

Open Access

20

Advanced nanobiomaterials: Vaccines, diagnosis and treatment of infectious diseases

Molecules

July 2016

Torres-Sangiao E.

Open Access